Explore funding opportunities dedicated to driving healthcare innovation. Whether you're developing groundbreaking solutions or leading collaborative research projects, our funding directory highlights valuable support to help bring your ideas to life.
The list below provides an overview of current funding opportunities and is updated regularly. Please note, this is not an exhaustive directory and only highlights a selection of available calls.
Our funding team has access to a comprehensive global database of funding calls and initiatives. If you're seeking a more extensive and tailored search to find the right opportunities for your innovation, we’re here to help.
Contact us at fundingsupport@lshubwales.com for guidance, bid review and editing, and help finding the perfect opportunity for your project. Last updated: May 2025
This Funding Opportunity Announcement encourages applications that investigate the biology and underlying mechanisms of bladder cancer. Bladder cancer is a significant health problem globally. Because of the high incidence and frequent tumour recurrence, bladder cancer exacts an outsized medical burden. While recent progress has been made in the molecular profiling of bladder cancers and identification of mutated genes, relatively little is known regarding the molecular mechanisms driving initiation, progression and malignancy of bladder cancer. Furthermore, understanding of the biological processes of the normal bladder at the molecular, cell and organ levels is limited. Fundamental knowledge of how molecular and cellular functions of the bladder are altered in cancer will aid understanding of bladder cancer biology and contribute to the future development of new interventions.
This international scheme aims to catalyse a revolution in the prevention, diagnosis and treatment of cancer, with awards of up to $25m available for innovative, game-changing research aligned with specified Grand Challenges in cancer research.
The 2025 call invites proposals addressing one of seven identified Grand Challenges: AI-human collaboration, cancer avoidance in high-risk groups, the dark proteome, unexplained mutational signatures, cancer–nervous system interactions, rewiring cancer cells, and tumour microenvironment dynamics. Projects must offer novel thinking and incorporate expertise not traditionally applied to cancer, with a clear trajectory toward prevention, diagnosis, or treatment.
Wellbeing of Women's Research Training Fellowships support individuals pursuing a career in academic medicine within obstetrics, gynaecology, or women’s reproductive health. Fellowships can fund basic science, clinical, or translational research, including feasibility studies and systematic reviews, that address clinical or patient needs and aim to improve health outcomes. Projects may be new or ongoing, but must include substantial training leading to a higher degree. All fellowships must be based at a UK research institution.
The MS Society Catalyst Award provides support over a maximum of 12 months for short-term, small-scale pilot or proof of concept research projects to explore innovative ideas in MS research. Projects should be hypothesis driven and may be 'high-risk, high-reward' in nature.
Support for research teams to build resilience into the delivery of health and social care services through interventions and solutions that are designed to minimise the impact of extreme weather events.
A European Commission prize for academic and research institutions in EU Member States and Horizon Europe associated countries to recognise their achievements in implementing gender equality measures.
Apply for funding to undertake ambitious interdisciplinary research to tackle epidemic diseases of animals, humans or plants for a duration of up to five years.
Apply for funding to run a scheme at your research organisation (RO) to reimburse public partners who work with researchers to develop Medical Research Council (MRC) research funding applications.
Grants to support early career researchers in the UK undertaking translational or proof of concept research in any area of gastroenterology (including pancreatology and hepatology).
Funding available to UK organisations and educational establishments for the funding of capital infrastructure in the fields of science and medicine, health, education and the arts and humanities.
Entry Level Scholarships to enable candidates to develop research interests in obstetrics, gynaecology, midwifery, maternity services and women’s reproductive health.
Funding to enable researchers of Black, Bangladeshi and Pakistani heritage in the UK to undertake activities that put them in a stronger position to reach their next career stage.
Support for longitudinal dataset projects to develop innovative ways of identifying anxiety, depression and/or psychosis so that, in time, people may benefit from better targeted early interventions.
Funding for joint UK-Australia platform studies (ie multi-arm studies to evaluate multiple interventions) in areas of unmet medical need where there is a pipeline of technologies that justifies such an approach.
Doctoral funding programme for research institutions in the UK to host PhD research projects focusing on the molecular and cellular basis of retinal degeneration.
Fellowship funding over a maximum of three years to support mid-career researchers conducting research that will advance knowledge and understanding of self-harm and suicide.
Projects should aim to develop new methodologies, frameworks, tools, or techniques that benefit health-related research. Proposals must align with Wellcome’s discovery research remit and can be single-discipline or multidisciplinary, spanning areas such as STEM, experimental medicine, clinical and allied health sciences, public health, humanities, and social sciences.
A prize is open to researchers in the UK to recognise sustained excellence in translational neuroscience (neurology and related clinical and academic disciplines).
HIS offers research grants to support research projects in the field of healthcare-associated infections (HCAIs) and infection prevention and control in the UK or Ireland. The thematic focus is on translational research.
This award aims to accelerate and drive forward the development of novel drugs for the treatment of Parkinson's. The initiative should provide researchers with the opportunity to generate essential data and help bridge the gaps needed to get their projects/compounds ready to enter full scale drug discovery with an industry partner.
A funding model supported by the Vanguard Initiative, which is a collaborative programme supporting industrial modernisation and innovation through industry-led and cross-regional cooperation.
Fellowships are available for European and Japanese researchers from any discipline to carry out a research visit in either Japan or Europe, respectively.
Funding for investigator-led research proposals that meet the remit and mission of the BBSRC, including research projects, new facilities or infrastructure provision, pilot projects, proof of concept studies, equipment purchase and research networks.
This Funding Opportunity Announcement (FOA) supports discrete, well-defined projects in any area of cancer research using the National Institutes of Health R03 small grant mechanism. The National Institutes of Health R03 small grant mechanism supports discrete, well-defined projects that realistically can be completed in two years and that require limited levels of funding. Examples of the types of projects that the R03 grant mechanism include, but are not limited to, the following: Pilot or feasibility studies.Secondary analysis of existing data.Small, self-contained research projects.Development of research methodology.Development of new research technology.
This Notice of Funding Opportunity (NOFO) invites mechanistic research that aims to understand how and why expectancy effects occur in a cancer context, elucidate their role in cancer symptom management, and identify patients, symptoms, cancer sites and contexts in which expectancy effects can be leveraged to improve cancer outcomes. Expectancies are defined in this context as beliefs about future outcomes, including one's response to cancer or cancer treatment. Expectancies can be evoked by social, psychological, environmental and systemic factors. Expectancy effects are the cognitive, behavioural and biological outcomes caused by expectancies. Expectancy effects can be generated by expectancies held by patients, clinicians, family members, caregivers and/or dyadic/social networks.
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) is inviting research projects that implement early phase (Phase 0, I and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of NCI's Division of Cancer Treatment and Diagnosis (DCTD) and Office of HIV and AIDS Malignancies (OHAM). The proposed project must involve at least one clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program, and/or the HIV and AIDS Malignancies Research Programs.
